In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 30th, 2008 | 13 | Yes |
Popular Name: Theophylline Theophylline
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 153719-23-4 , 317-34-0 , 4499-40-5 , 5634-34-4 , 58-55-9 , 5967-84-0 , 5967-84-0, 58-55-9 , 5967-84-0, 58-55-9 [anhydrous] , 8000-10-0 , 8002-89-9 , [153719-23-4] , [317-34-0] , [3485-82-3] , [5634-34-4] , [56770-95-7] , [8000-10-0]
(2-Hydroxyethyl)trimethylammonium compound with theophylline
1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine
1,3-Dimethyl-3,7-dihydro-purine-2,6-dione; compound with ethane-1,2-diamine
1,3-dimethyl-3,9-dihydro-1H-purine-2,6-dione
1,3-dimethyl-7H-purine-2,6-dione
1,3-dimethyl-7H-purine-2,6-dione; ethane-1,2-diamine
1,3-dimethyl-7H-purine-2,6-dione; Theophyllin; theophylline; theophylline anhydrous
1,3-Dimethylxanthine monohydrate
1,3-Dimethylxanthine; 58-55-9; C07130; Theophylline
1,3-dimethylxanthine; CPD-12479; theophylline
1H-purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, ion(1-), 2-hydroxy-N,N,N-trimethylethanaminium
2-hydroxyethyl(trimethyl)azanium
3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione calcium salt
3-(2-Chloro-5-thiazolylmethyl)tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine
317-34-0; Aminophylline (USP/INN); D00227; Somophyllin (TN); Theophylline ethylenediamine (TN)
317-34-0; Aminophylline; Prestwick_93
5634-34-4; Ambuphylline (USAN); Bufylline (BAN); Butaphyllamine (TN); D02884
58-55-9; CPD000058537; SAM002554935; Theophylline
5967-84-0; Accurbron (TN); D06103; Theophylline (USP); Theophylline monohydrate
5967-84-0; Prestwick_1055; Theophylline monohydrate
8000-10-0; Asbron (TN); D06104; Theophylline sodium glycinate (USP)
8002-89-9; D01712; Theophylline sodium acetate (JAN)
Aminophyllin;Aminophylline Anhydrous;Aminophylline Dihydrate;Aminophylline Dye Free
Aminophylline hydrate (JP16); D05429
CHEBI:45950; CHEBI:9523; CHEBI:26940
Choline salt with theophylline (1:1)
Choline, compd. with theophylline (1:1)
Choline, hydroxide, compd. with theophylline (1:1)
Cholini theophyllinas [INN-Latin]
CPD000058537; SAM002554935; Theophylline
Elixophyllin; Respbid; Theo-Dur; Theolair; Uniphyl
Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione
Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethylpurine-2,6-dione
Glycine, sodium salt, compd. with theophylline; LS-72876; Sodium theophylline glycinate
INN); Choline Theophylline (JAN); Oxtriphylline (FDA
sodium 1,3-dimethyl-7H-purine-2,6-dione acetate
Somopphyllin, Aminocadol, Phyllocontin
Teofilinato de colina [INN-Spanish]
Theophyllinate de choline [INN-French]
Theophylline Sodium Glycinate (FDA
Theophylline, compd. with choline
USP); Ambuphylline (USAN); Bufylline (BAN); Theophylline Olamine (USP)
USP); Choline Theophyllinate (BAN
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.00 | 3.24 | -11.33 | 1 | 6 | 0 | 73 | 180.167 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Diuretic | ZereneX Building Blocks |
Molecular_Solubility | 0.956 | Bitter DB |
Molecular_Solubility | 2.054 | Bitter DB |
Molecular_Solubility | 0.024 | Bitter DB |
ALOGPS_SOLUBILITY | 2.29e+01 g/l | DrugBank-approved |
Mp [°C] | 270 - 274 | Acros Organics |
Melting_Point | 270-274? | Alfa-Aesar |
Melting_Point | 270-274° | Alfa-Aesar |
MP | 274 - 276 | Enamine Building Blocks |
MP | 274...276 | Enamine Building Blocks |
ALOGPS_SOLUBILITY | 3.84e+00 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 97% | Fluorochem |
UniProt Database Links | ANMT_RUTGR; GR66A_DROME; NDMA_PSEPU; NDMB_PSEPU; PSB10_RAT; PSB1_RAT; PSB2_RAT; PSB5_RAT; PSB8_RAT; PSB9_RAT | ChEBI |
Indications | antiasthmatic, bronchospasm | KeyOrganics Bioactives |
therap | bronchodilator | MicroSource Spectrum |
Target | C-C chemokine receptor type 5(P51681)&Catalase(P04040)&Resistin(Q9HD89)&Alkaline phosphatase, tissue-nonspecific isozyme(P05186)&Calcium/calmodulin-dependent protein kinase kinase 2(Q96RR4)&Superoxide dismutase [Cu-Zn](P00441)&Insulin-like growth factor 1 | Herbal Ingredients Targets |
mechanism | Calcium antagonist | IBScreen Bioactives |
biological_use | Cardiac stimulant | IBScreen Bioactives |
mechanism | CNS stimulant | IBScreen Bioactives |
biological_use | Diuretic | IBScreen Bioactives IBScreen Bioactives |
Therapy | Diuretic; cardiac stimulant; smooth muscle relaxant; water soluble complex of theophylline | SMDC Iconix |
PUBCHEM_PATENT_ID | EP0162747A1; EP0162764A1; EP0206947A2; EP0206947B1; EP0214898A2; EP0214898B1; EP0215697A2; EP0215697B1; EP0222664A2; EP0227531A2; EP0737066A1; EP0769938B1; EP1021204A2; US4537772; US4677131; US4692441; US4729989; US4731360; US4749694; US4762851; US4822773 | IBM Patent Data |
PUBCHEM_PATENT_ID | EP0895989A1 | IBM Patent Data |
Patent Database Links | EP1229034; EP1574501; EP1577291; EP1577292; EP1640006; EP1671972; EP1754712; EP1870093; GB2094142; US2003236298; US2004092536; US2004254182; US2004261190; US2005014763; US2005020587; US2005020611; US2005020626; US2005020639; US2005026952; US2005032838; US | ChEBI |
H phrase | H302: Harmful if swallowed | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : T-3611; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
P phrase | P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell | Acros Organics |
Target | PDE | Selleck Chemicals |
mechanism | Phosphodiesterase inhibitor | IBScreen Bioactives |
R phrase | R22: Harmful if swallowed. | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: T-3611; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
biological_use | Smooth muscle relaxant | IBScreen Bioactives |
Purity | USP25/BP2000 | APIChem |
mechanism | Vasodilator | IBScreen Bioactives IBScreen Bioactives |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA1R-2-E | Adenosine A1 Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 9800 | 0.54 | Binding ≤ 10μM |
AA2AR-1-E | Adenosine A2a Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 9400 | 0.54 | Binding ≤ 10μM |
AA2BR-1-E | Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9000 | 0.54 | Binding ≤ 10μM |
AA3R-2-E | Adenosine Receptor A3 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 14 | 0.85 | Binding ≤ 10μM |
ADCY2-1-E | Adenylate Cyclase Type II (cluster #1 Of 2), Eukaryotic | Eukaryotes | 940 | 0.65 | Binding ≤ 10μM |
ADCY3-1-E | Adenylate Cyclase Type III (cluster #1 Of 2), Eukaryotic | Eukaryotes | 940 | 0.65 | Binding ≤ 10μM |
ADCY4-1-E | Adenylate Cyclase Type IV (cluster #1 Of 2), Eukaryotic | Eukaryotes | 940 | 0.65 | Binding ≤ 10μM |
ADCY5-1-E | Adenylate Cyclase Type V (cluster #1 Of 2), Eukaryotic | Eukaryotes | 940 | 0.65 | Binding ≤ 10μM |
ADCY6-1-E | Adenylate Cyclase Type VI (cluster #1 Of 2), Eukaryotic | Eukaryotes | 940 | 0.65 | Binding ≤ 10μM |
ADCY8-2-E | Adenylate Cyclase Type VIII (cluster #2 Of 2), Eukaryotic | Eukaryotes | 940 | 0.65 | Binding ≤ 10μM |
AA2AR-1-E | Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4800 | 0.57 | Functional ≤ 10μM |
AA2BR-1-E | Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4800 | 0.57 | Functional ≤ 10μM |
Z50597-2-O | Rattus Norvegicus (cluster #2 Of 5), Other | Other | 9000 | 0.54 | Binding ≤ 10μM |
Z50512-5-O | Cavia Porcellus (cluster #5 Of 7), Other | Other | 6520 | 0.56 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA1R_RAT | P25099 | Adenosine A1 Receptor, Rat | 150 | 0.73 | Binding ≤ 1μM |
AA1R_HUMAN | P30542 | Adenosine A1 Receptor, Human | 0.6 | 0.99 | Binding ≤ 1μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 150 | 0.73 | Binding ≤ 1μM |
AA2AR_HUMAN | P29274 | Adenosine A2a Receptor, Human | 0.6 | 0.99 | Binding ≤ 1μM |
AA2BR_RAT | P29276 | Adenosine A2b Receptor, Rat | 150 | 0.73 | Binding ≤ 1μM |
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 14 | 0.85 | Binding ≤ 1μM |
AA3R_RAT | P28647 | Adenosine A3 Receptor, Rat | 150 | 0.73 | Binding ≤ 1μM |
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 940 | 0.65 | Binding ≤ 1μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 940 | 0.65 | Binding ≤ 1μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 940 | 0.65 | Binding ≤ 1μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 940 | 0.65 | Binding ≤ 1μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 940 | 0.65 | Binding ≤ 1μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 940 | 0.65 | Binding ≤ 1μM |
Z50597 | Z50597 | Rattus Norvegicus | 150 | 0.73 | Binding ≤ 1μM |
AA1R_BOVIN | P28190 | Adenosine A1 Receptor, Bovin | 2430 | 0.60 | Binding ≤ 10μM |
AA1R_RAT | P25099 | Adenosine A1 Receptor, Rat | 150 | 0.73 | Binding ≤ 10μM |
AA1R_HUMAN | P30542 | Adenosine A1 Receptor, Human | 0.6 | 0.99 | Binding ≤ 10μM |
AA2AR_HUMAN | P29274 | Adenosine A2a Receptor, Human | 0.6 | 0.99 | Binding ≤ 10μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 1310 | 0.63 | Binding ≤ 10μM |
AA2BR_RAT | P29276 | Adenosine A2b Receptor, Rat | 1310 | 0.63 | Binding ≤ 10μM |
AA2BR_HUMAN | P29275 | Adenosine A2b Receptor, Human | 2700 | 0.60 | Binding ≤ 10μM |
AA3R_RAT | P28647 | Adenosine A3 Receptor, Rat | 150 | 0.73 | Binding ≤ 10μM |
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 14 | 0.85 | Binding ≤ 10μM |
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 940 | 0.65 | Binding ≤ 10μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 940 | 0.65 | Binding ≤ 10μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 940 | 0.65 | Binding ≤ 10μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 940 | 0.65 | Binding ≤ 10μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 940 | 0.65 | Binding ≤ 10μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 940 | 0.65 | Binding ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 150 | 0.73 | Binding ≤ 10μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 4800 | 0.57 | Functional ≤ 10μM |
AA2BR_RAT | P29276 | Adenosine A2b Receptor, Rat | 4800 | 0.57 | Functional ≤ 10μM |
AA2BR_HUMAN | P29275 | Adenosine A2b Receptor, Human | 9070 | 0.54 | Functional ≤ 10μM |
Z50512 | Z50512 | Cavia Porcellus | 10000 | 0.54 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenosine P1 receptors | |
Adenylate cyclase activating pathway | |
Adenylate cyclase inhibitory pathway | |
G alpha (i) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
Glucagon signaling in metabolic regulation | |
NGF-independant TRKA activation | |
PKA activation | |
PKA activation in glucagon signalling | |
Vasopressin regulates renal water homeostasis via Aquaporins |